Optiscan Imaging Limited (ASX:OIL)

Market Cap	146.18M +40.0%
Revenue (ttm)	2.44M -50.9%
Net Income	-7.33M
EPS	-0.01
Shares Out	1.04B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	452,856
Open	0.1250
Previous Close	0.1250
Day's Range	0.1250 - 0.1400
52-Week Range	0.0790 - 0.1400
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Optiscan Imaging

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinica...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1994
• Employees: 9
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OIL

Financial Performance

In fiscal year 2025, Optiscan Imaging's revenue was 3.72 million, an increase of 24.72% compared to the previous year's 2.99 million. Losses were -6.31 million, 4.15% more than in 2024.